Skip to main content

Levofem

A combination medicine containing combined oral contraceptives, by DKT International — tablet, made in Indonesia.

NAFDAC registration

Our August 2026 copy of the NAFDAC Greenbook records the listing Levofem (B4-2586), applicant Deep K. Tyagi Foundation Nigeria, with status Expired. Listings can lag renewals — confirm the current status on the official Greenbook before buying.

The applicant is the Nigerian company that holds the NAFDAC registration for this product — for imported brands this is often a local distributor rather than the maker.

Levofem at a glance

Manufacturer
DKT International
Made by (factory)
PT. Harsen Laboratories
Form
Tablet
Composition
  • Ethinylestradiol 0.03 mg
  • Levonorgestrel 0.15 mg
  • Ferrous fumarate 75 mg
Made in
Indonesia
NAFDAC reg. no.
B4-2586

Levofem price in Nigeria

One listing of Levofem at HealthPlus was priced ₦1,600 as of September 2026.

  • Levofem 0.15Mg/0.03Mg X84(HealthPlus)₦1,600

Sampled from licensed Nigerian online pharmacies — 1 listing of Levofem, indicative only. Track month-by-month movement on the Medicine Price Index.

About Combined Oral Contraceptives

Combined oral contraceptives (COCs), commonly known as 'the pill' or family planning pills, are tablets containing two types of female hormones — an oestrogen (usually ethinyl estradiol) and a progestogen (such as levonorgestrel, desogestrel, or norgestrel). These hormones work together to prevent pregnancy through three main mechanisms: they suppress ovulation (the release of an egg from the ovaries), they thicken the cervical mucus making it difficult for sperm to reach the egg, and they alter the uterine lining making it less receptive to a fertilised egg. When taken correctly — one tablet every day at approximately the same time — combined oral contraceptives are more than 99% effective at preventing pregnancy. In Nigeria, where the maternal mortality ratio remains one of the highest in the world and unintended pregnancies contribute significantly to unsafe abortions and maternal deaths, access to effective family planning methods including COCs is a critical public health priority.

Read the full Combined Oral Contraceptives guide — dosage, side effects, warnings, and all registered brands.

Frequently asked questions

Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: August 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated September 2026.